Sitemap

December 28, 2016 Articles

Filter by Available Specialty
  1. EFORT Open Reviews: A round-up of recently published articles
  2. Listeria-related deaths increase in Europe
  3. 18th EFORT Annual Congress in Vienna: A closer look at sports and orthopaedics
  4. 2016 year in review: Miracles do happen
  5. A look at how MIPS will affect every ophthalmologist
  6. AAP warns against use of unscreened, internet-purchased breast milk
  7. ACOG urges OB/GYNs to support transgender teens
  8. AMA releases seven health recommendations for 2017
  9. Association of Pediatric Hematology/Oncology Nurses presents leadership awards
  10. Autologous platelet-rich plasma glue improves outcomes in limb lift, breast reduction surgery
  11. Bausch + Lomb raises $40k+ for Optometry Giving Sight
  12. Biomechanical modeling, fast-track surgery among highlights of 18th EFORT Annual Congress in Vienna
  13. BLOG: Osteoporosis primer for physician assistants, part 1
  14. BLOG: ReSTOR toric approval a major breakthrough
  15. CHMP recommends approval for baricitinib for moderate to severe active RA
  16. Deferred stenting safe but not beneficial in patients with STEMI
  17. Disparities in access to diabetes care observed within Appalachian counties
  18. DTC tied to decreased physical functioning, increased mental fatigue
  19. Ebola vaccine 100% effective in major trial
  20. Education, planning improvements needed for pediatric diabetes patients transitioning to adult care
  21. EFORT Fora sessions can enhance European national congresses
  22. Experts at 18th EFORT Annual Congress to focus on trauma, pediatric orthopaedics
  23. Experts define treatment failure for chronic constipation
  24. FDA grants orphan drug designation to ES-3000 for AML
  25. HCC most common indication for LT, waitlist placement in US
  26. In patients undergoing noncardiac surgery, death and MI declining, but stroke increasing
  27. In patients with ACS undergoing CABG, ticagrelor confers similar risk for bleeding vs. aspirin
  28. Increasing costs, mortality rates related to admissions for COPD exacerbations
  29. ISASS issues guidance on decompression with interlaminar stabilization
  30. Kubota Pharma, SBI Holdings form joint venture
  31. Lifetime substance use may increase risk for postpartum depression
  32. Lower IQ found in some adolescent psychiatric disorders
  33. Lung health at risk in teen e-cigarette users
  34. Macular thickness reduced more with dexamethasone than bevacizumab in DME
  35. Medicare payment adjustments to be based on quality and cost
  36. Melanoma rate is rising in US
  37. Ozurdex given at same time as PPV may help stabilize retinal conditions
  38. Precision Spine receives 510(k) clearance for AccuFit Lateral Plating System
  39. Selumetinib appears beneficial for children with inoperable plexiform neurofibromas
  40. Several non-ocular risk factors identified with severe dry eye symptoms
  41. Some stem cell clinics pose threat to patients seeking AMD treatment
  42. Stent retriever cost-effective in acute ischemic stroke
  43. Study cites factors correlated with hospital readmission following fusion for pediatric spinal deformity
  44. Study: Biomarker test may help predict RA treatment response
  45. Study: Culture-negative, culture-positive infections should receive similar treatment
  46. Subcutaneous ICD use linked to low in-hospital complication rates
  47. Survey: Referral rate for low vision services low among glaucoma specialists
  48. Thiazide use safe, effective in primary hyperparathyroidism
  49. Top cosmetic dermatology news of 2016 includes Juvéderm, Kybella
  50. Top depression articles of 2016
  51. Top five glaucoma articles of 2016
  52. Transient thelarche may not affect subsequent pubertal development
  53. VIDEO: Addition of brentuximab vedotin to salvage chemotherapy ‘sets stage’ for future studies
  54. VIDEO: Hanauer discusses importance of early positioning, head-to-head trials of IBD therapies
  55. VIDEO: Lesinurad offers gout patients a new choice
  56. VIDEO: Oncologist questions use of extended endocrine therapy in breast cancer
  57. What measures are you taking to prepare for MIPS?